Assessment of liver damage in patients with COVID-19 is sub-optimal: results of a survey of medical practitioners.
Rev Esp Enferm Dig
; 114(1): 50-52, 2022 01.
Article
en En
| MEDLINE
| ID: mdl-33820421
ABSTRACT
Liver damage, defined by an increase in liver chemistry parameters, is related to more unfavorable severity and prognosis in patients with COVID-19. These patients are also treated with immunomodulatory drugs capable of reactivating hepatitis B virus (HBV), with an indication for prophylaxis in specific situations. Due to its importance in this pathology, we wondered whether physicians should perform a systematic search for liver damage and HBV.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Hepatitis B Crónica
/
COVID-19
/
Hepatitis B
Límite:
Humans
Idioma:
En
Revista:
Rev Esp Enferm Dig
Asunto de la revista:
GASTROENTEROLOGIA
Año:
2022
Tipo del documento:
Article